search for



KCI

Crossref

Cross mark

Cited-by

Fundref

TDM

View (49) Download (27) CrossRef (1)
The Impact of Cigarette Smoking on the Incidence of Lung and Laryngeal Cancer
J Korean Soc Res Nicotine Tob 2024; 15(2): 42-48
Published online June 30, 2024
© 2024 The Korean Society for Research on Nicotine and Tobacco.

Heejin Kimm1,2, So Young Kim3, Yeun Soo Yang1,2, Keum Ji Jung1,2, Sunmi Lee3, Sun Ha Jee1,2*

1Institute for Health Promotion, Graduate School of Public Health, Yonsei University, Seoul, 2Department of Epidemiology and Health Promotion, Graduate School of Public Health, Yonsei University, Seoul, 3Health Insurance Research Institute, National Health Insurance Service, Wonju, Korea
Correspondence to: *吏꽑븯
뿰꽭븰援 蹂닿굔븰썝 뿭븰嫄닿컯利앹쭊븰怨, 援誘쇨굔媛뺤쬆吏꾩뿰援ъ냼
E-mail: jsunha@yuhs.ac
ORCID: https://orcid.org/0000-0001-9519-3068
Received April 18, 2024; Revised June 17, 2024; Accepted June 19, 2024.
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, dis-tribution, and reproduction in any medium, provided the original work is properly cited.
 Abstract
Background: Smoking has been identified as the most substantial risk factor for lung and laryngeal cancer; however, research on their histological classification remains scarce. Therefore, our research team conducted a prospective cohort analysis to investigate the relationship between smoking and incidence of small cell lung carcinoma, lung squamous cell carcinoma, lung adenocarcinoma, and laryngeal squamous cell carcinoma.
Methods: This study investigated a prospective cohort of 159,844 participants included in The Korean Cancer Prevention Study-II who visited 18 nationwide health examination centers for screening purposes from 2004 to 2013. Incidence of cancer and chronic diseases among the study participants was confirmed by linking their data with those published in the National Cancer Center registry and National Health Insurance Service. After excluding cases with missing smoking duration and pack-years, the final cohort comprised 141,679 individuals. Using Cox proportional hazards models adjusting for sex, age, and alcohol consumption, relative risks for lung and laryngeal cancer according to histological subtype were calculated based on smoking duration and pack-years, along with attributable risks.
Results: Mean follow-up period for the 141,679 participants was 12.9 years (standard deviation 1.6), accumulating a total of 1,827,451 person-years. Among current smokers, 19.7% had smoked for less than 30 years with at least 20 pack-years, whereas 9.4% had smoked for 30 years or more with at least 20 pack-years. Among all the participants, 741 developed lung cancer, with an incidence rate of 42.8 per 100,000 person-years. Histological subtypes included small cell lung carcinoma (43 cases), pulmonary squamous cell carcinoma (133 cases), pulmonary adenocarcinoma (489 cases), and laryngeal squamous cell carcinoma (45 cases). The relative risk of incident cancer among current smokers who had smoked for over 30 years with more than 20 pack-years was 41.2 (95% CI, 5.5-310), 28.4 (95% CI, 11.4-70.9), 4.4 (95% CI, 2.9-6.8), and 6.8 (95% CI, 2.2-21.2) times greater among those with small cell lung cancer, pulmonary squamous cell carcinoma, pulmonary adenocarcinoma, and laryngeal squamous cell carcinoma, respectively, than among never smokers. Their attributable risks for cancer incidence were 97.5%, 96.4%, 77.2%, and 85.3%, respectively.
Conclusion: This study provides evidence that smoking is a potent risk factor for lung cancer incidence, specifically for small cell lung cancer and pulmonary squamous cell carcinoma, wherein smoking contributes to over 96% of the risk.
Keywords : Smoking; Lung cancer; Histological type; Attributable risk
References
  1. Jee SH, Samet JM, Ohrr H, Kim JH, Kim IS. Smoking and cancer risk in Korean men and women. Cancer Causes Control. 2004; 15(4): 341-8.
    Pubmed CrossRef
  2. Myong JP, Kim H, Lee K, Chang SH. Trends in the of epidemiological perspectives on the causality of occupational diseases. J Korean Med Assoc. 2018; 61(8): 466-73.
    CrossRef
  3. Park H, Kang JH. Precision Medicine in Head and Neck Cancer. Korean J Head Neck Oncol. 2023; 39(1): 1-9.
    CrossRef
  4. Kim SY, Ham EK. Pathological study of malignant tumors of larynx. K. J. Path. 1986; 20(3): 313-21.
  5. Ad-hoc Committee of the Korean Society for Preventive Medicine and the Korean Society of Epidemiology on Tobacco Lawsuits. Joint Statement of the Ad-hoc Committee of the Korean Society for Preventive Medicine and the Korean Society of Epidemiology on Tobacco Lawsuits on the causal link between tobacco smoking and lung cancer. J Prev Med Public Health. 2015; 48: 119-31.
    Pubmed KoreaMed CrossRef
  6. Yun YH, Lim MK, Jung KW, Bae JM, Park SM, Shin SA, et al. Relative and absolute risks of cigarette smoking on major histologic types of lung cancer in Korean men. Cancer Epidemiol Biomarkers Prev. 2005; 14(9): 2125-30.
    Pubmed CrossRef
  7. Korean Medical Association. English-Korean, Korean-English Medical Terminology, 6th edition, 2020.
  8. Thun MJ, Hannan LM, Adams-Campbell LL, Boffetta P, et al. Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med. 2008; 5(9): e185.
    Pubmed KoreaMed CrossRef
  9. Jee SH, Jo IH, Yun JE, Pa r k JY, Sull JW, Ohrr HC, Lee SY, Yoon YS, Samet JM, Kim IS. Smoking and cause of death in Korea: 11 years follow-up prospective study. Korean Journal of Epidemiology. 2005; 27(1): 182-90.
  10. Doll R, Pete R. Mortality in relation to smoking: 20 years’ observations on male British doctors. Br Med J. 1976; 2: 1525-36.
    Pubmed KoreaMed CrossRef
  11. Doll R, Pete R, Wheatley K, Sutherland I. Mortality in relation to smoking: 40 years observations on male British doctors. Br Med J. 1994; 309: 901-11.
    Pubmed KoreaMed CrossRef
  12. Hoffmann D, Rivenson A, Hecht SS. The biological significance of tobacco-specific N-nitrosamines: smoking and adenocarcinoma of the lung. Crit Rev Toxicol. 1996; 26(2): 199-211.
    Pubmed CrossRef